Literature DB >> 33861381

Mortality risk associated with endophthalmitis in West Virginia.

Jeffrey Desilets1, Chang Sup Lee2, Wei Fang3, David M Hinkle4,5.   

Abstract

PURPOSE: To explore how endophthalmitis presented from 2009 to 2019 in a West Virginia population particularly affected by the national opioid crisis. The analysis explores the relationship between the type of endophthalmitis and mortality, accounting for factors including age, gender, type of organism, and intravenous drug use (IVDU).
METHODS: The electronic health record of West Virginia University (WVU) Medicine was queried for all patients managed for endophthalmitis from October 2009 to October 2019. For each of the included subjects, age, gender, history of IVDU, culture results, concomitant endocarditis, type of endophthalmitis, and the date of diagnosis were extracted. Mortality data were obtained from WVU's electronic medical record, the Social Security Death Index, and public obituaries. Mortality results were represented by a Kaplan-Meier Survival curve following each patient for one year from the date of diagnosis. Results were analyzed using unadjusted and adjusted Cox Proportional Hazard models.
RESULTS: One-year mortality was 14 out of 113 endogenous cases (12.4%) compared to 6 out of 173 exogenous cases (3.5%). Endogenous endophthalmitis cases had significantly higher mortality than exogenous ones within one year of diagnosis (p = 0.0034). The unadjusted Cox proportional hazards model revealed that the type of endophthalmitis (endogenous vs. exogenous) was the only variable with a significant impact on 1-year mortality with a hazard ratio of 3.78 (p = 0.01). However, the hazard ratio for endogenous infections rose to 10.91 (CI 3.544-33.595) when the other variables of age, gender, organism, and IVDU were controlled (p < 0.01). The Cox proportional hazard ratios for age group, gender, organism type, and history of IVDU were not significantly different when adjusted for all other variables.
CONCLUSION: Endogenous cases, which were significantly overrepresented in West Virginia, were associated with a significantly higher 1-year mortality rate than the exogenous ones. Age, gender, organism type, and history of IVDU have less, if any, modifying effect on mortality.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Drug use-related endophthalmitis; Endogenous endophthalmitis; Exogenous endophthalmitis

Mesh:

Year:  2021        PMID: 33861381      PMCID: PMC8422286          DOI: 10.1007/s10792-021-01849-3

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.029


  20 in total

1.  Presentation and outcome of a cluster of patients with endogenous endophthalmitis: a case series.

Authors:  J Guber; M U Saeed
Journal:  Klin Monbl Augenheilkd       Date:  2015-04-22       Impact factor: 0.700

2.  Epidemiology and Mortality-Related Prognostic Factors in Endophthalmitis.

Authors:  Tzu-Heng Weng; Hsu-Chieh Chang; Chi-Hsiang Chung; Fu-Huang Lin; Ming-Cheng Tai; Chang-Huei Tsao; Ke-Hung Chien; Wu-Chien Chien
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-05-01       Impact factor: 4.799

3.  Clinical features and prognostic factors of Klebsiella endophthalmitis-10-year experience in an endemic region.

Authors:  C Y Chung; E S Wong; C C H Liu; M O M Wong; K K W Li
Journal:  Eye (Lond)       Date:  2017-06-16       Impact factor: 3.775

4.  Intravenous Drug Use-Associated Endophthalmitis.

Authors:  Bobeck S Modjtahedi; Avni P Finn; Thanos D Papakostas; Marlene Durand; Deeba Husain; Dean Eliott
Journal:  Ophthalmol Retina       Date:  2017-01-16

Review 5.  Endogenous bacterial endophthalmitis: an east Asian experience and a reappraisal of a severe ocular affliction.

Authors:  J S Wong; T K Chan; H M Lee; S P Chee
Journal:  Ophthalmology       Date:  2000-08       Impact factor: 12.079

Review 6.  Bacterial and Fungal Endophthalmitis.

Authors:  Marlene L Durand
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

Review 7.  Endophthalmitis: Then and Now.

Authors:  Nidhi Relhan; Richard K Forster; Harry W Flynn
Journal:  Am J Ophthalmol       Date:  2017-12-05       Impact factor: 5.258

8.  Endogenous endophthalmitis: an 18-year review of culture-positive cases at a tertiary care center.

Authors:  Monica I Binder; Jimmy Chua; Peter K Kaiser; Gary W Procop; Carlos M Isada
Journal:  Medicine (Baltimore)       Date:  2003-03       Impact factor: 1.889

9.  A Prospective Study on the Clinical and Microbiological Spectrum of Endophthalmitis in a Specific Region in Denmark.

Authors:  Søren Solborg Bjerrum; Hassan Hamoudi; Alice Friis-Møller; Morten la Cour
Journal:  Ophthalmologica       Date:  2015-12-04       Impact factor: 3.250

10.  Mortality after endophthalmitis following contemporary phacoemulsification cataract surgery.

Authors:  Niall Crosby; Philip J Polkinghorne; Bia Kim; Charles Nj McGhee; Sarah Welch; Andrew Riley
Journal:  Clin Exp Ophthalmol       Date:  2018-05-10       Impact factor: 4.207

View more
  1 in total

1.  The microbiological spectrum, antimicrobial resistance pattern, and visual outcomes of endogenous endophthalmitis in West Virginia 2009-2019.

Authors:  Chang Sup Lee; Jeffrey Desilets; Wei Fang; David M Hinkle
Journal:  Int Ophthalmol       Date:  2022-05-23       Impact factor: 2.029

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.